Page 140 - Pagetit
P. 140
4. PSYCHOPHARMACOLOGY OF DEPENDENCE FOR DIFFERENT DRUG CLASSES
Naruse T, Asami T (1990) Cross-dependence on ethanol and pentobarbital in rats
reinforced on diazepam. Archives of International Pharmacodynamic Therapy,
304:147–162.
Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction.
Nature Reviews in Neuroscience, 2:119–128.
Newcomer JW et al. (1999) Ketamine-induced NMDA receptor hypofunction as
a model of memory impairment and psychosis. Neuropsychopharmacology,
20:106–118.
Nichols DE (1986) Differences between the mechanism of action of MDMA,
MBDB, and the classic hallucinogens. Identification of a new therapeutic class:
entactogens. Journal of Psychoactive Drugs, 18:305–313.
Nutt DJ, Malizia AL (2001) New insights into the role of the GABA(A)
benzodiazepine receptor in psychiatric disorder. British Journal of Psychiatry,
179:390–396.
O´Brien CP (2001) Drug addiction and drug abuse. In: Goodman and Gilman’s:
The pharmacological basis of therapeutics, 10th ed. New York, McGraw Hill:621–
667.
Ong WY, Mackie K (1999) A light and electron microscopic study of the CB1
cannabinoid receptor in primate brain. Neuroscience, 92:1177–1191.
Panagis G et al. (2000) Effects of methyllycaconitine (MLA), an alpha-7 nicotinic
receptor antagonist, on nicotine- and cocaine-induced potentiation of brain
stimulation reward. Psychopharmacology (Berlin), 149:388–396.
Panksepp J (1998) Affective neuroscience: the foundations of human and animal
emotions. New York, NY, Oxford University Press.
Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clinical
Pharmacology, 16:1–18.
Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain.
Progress in Neurobiology, 61:75–111.
Perkins KA et al. (1993) Chronic and acute tolerance to subjective effects of
nicotine. Pharmacology, Biochemistry and Behavior, 45:375–381.
Peroutka SJ (1989) “Ecstasy”: a human neurotoxin? Archives of General Psychiatry,
46:191.
Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors.
Pharmacology and Therapeutics, 74:129–180.
Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Current
Medicinal Chemistry, 6:635–664.
Pertwee RG (2001) Cannabinoid receptors and pain. Progress in Neurobiology,
63:569–611.
Pfefferbaum A et al. (1998) A controlled study of cortical gray matter and
ventricular changes in alcoholic men over a 5-year interval. Archives of General
Psychiatry, 55:905–912.
Phillips AG, Brooke SM, Fibiger HC (1975) Effects of amphetamine isomers and
neuroleptics on self-stimulation from the nucleus accumbens and dorsal
noradrenergic bundle. Brain Research, 1:13–22.
119
Chapter_4 119 19.1.2004, 11:44